Yahoo España Búsqueda web

Search results

  1. 6 de may. de 2024 · Hoffmann-La Roche, Fritz. 1868 - 1920. Données biographiques. Nom : Hoffmann-La Roche. Prénom : Fritz. Sexe : H. Naissance : 24.10.1868. Décès : 18.04.1920. Lieu naissance : Bâle (BS) Nationalité : Suisse. Principales professions : Fondateur de Hoffmann-La Roche. Formation. Universitaire : non. base. année. titre. catégorie. lieu. pays. -

  2. www.forbes.com › profile › maja-oeriMaja Oeri - Forbes

    Hace 4 días · Pharmaceuticals. Residence. Basel, Switzerland. Citizenship. Switzerland. Marital Status. Married. Did you know. #1104 Maja Oeri on the 2024 Billionaires - Maja Oeri is a descendant of Fritz...

  3. Hace 2 días · Hoffmann Family 64.97 % 69,318,000 : 64.97 % 18 200 M ... screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958.

  4. 23 de abr. de 2024 · April 23, 2024. RG-6631 by F. Hoffmann-La Roche for Ulcerative Colitis: Likelihood of Approval. Brought to you by. F. Hoffmann-La Roche. RG-6631 is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Ulcerative Colitis.

  5. 24 de abr. de 2024 · F. Hoffmann-La Roche has patented a method for generating a module to determine analyte concentration in body fluid samples. The method involves using image data from test strips, recorded by various devices, to train a neural network model for accurate analysis.

  6. 23 de abr. de 2024 · F. Hoffmann-La Roche. RG-6457. RG-6457 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 70% phase transition success rate (PTSR) indication benchmark for progressing into Phase II.

  7. 19 de abr. de 2024 · April 19, 2024 01:00 ET | Source: F. Hoffmann-La Roche Ltd. Follow. Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or death by an...